Clinical Trial Update: A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

The document reports completion of a Phase 3 trial evaluating adjunctive aripiprazole for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED